All In Biotech

Drug Trial Radar · NCT07382661

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetics Drug-drug Interaction of DW4421 and Amoxicillin/Clarithromycin in Healthy Adult Volunteers

Last checked: Nov 20, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Feb 2026

Primary completion

May 2026

Study completion Oct 2026

Sponsor

Sponsor type
Industry
First posted
Feb 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin

Conditions

  • Healthy Adult Volunteers

Interventions

  • DW4421Drug

    1 tablet will be orally administered

  • DW4421-1Drug

    2 capsules will be orally administered

  • DW4421-2Drug

    1 tablet will be orally administered

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax,ss: Maximum concentration of DW4421, DW4421-1 and DW4421-2 at steady stateTime frame: Up to day 6 or day 7
  2. AUCτ,ss: Area under the drug concentration-time curve of DW4421, DW4421-1, DW4421-2 within a dosing interval at steady stateTime frame: Up to day 6 or day 7

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chungbuk National University Hospital

    Cheongju-si, North Chungcheong, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.